CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on discovering new antimicrobial peptides (AMPs) to combat antimicrobial resistance (AMR). By analyzing dominant commensal genomes, it aims to identify effective AMPs that can eradicate pathogens and reduce AMR development, utilizing advanced computational methods and in-vitro techniques.
Abuse and overuse of antibiotics has led to antimicrobial resistance (AMR), which is a major global health concern.
In the EU, there are around 30,000 AMR-related deaths per year, and the incidence of AMR is on the rise; experts have predicted a loss of 10 million lives by 2050.
One of the reasons to find alternatives to tackle this grave and complicated health challenge is that only very few antibiotics are discovered and those in the pipeline do not have the ability to circumvent AMR developme…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
